CapVest Partners on Monday boosted its offer for IVF player Virtus Health and won the backing of the target’s board, thwarting a last-minute attempt by rival BGH Capital to snare the 80 per cent of the company it does not already own.
Virtus’ trading halt was lifted on Monday and its shares climbed 2¢ to $8.17 after the news that it had received a fresh offer from CapVest – the eighth competing bid from the two private equity firms since mid-December.
Loading...
Carrie LaFrenz is a senior journalist covering retail/consumer goods. She previously covered healthcare/biotech. Carrie has won multiple awards for her journalism including financial journalist of the year from The National Press Club. Connect with Carrie on Twitter. Email Carrie at carrie.lafrenz@afr.com
